- Previous Close
0.9558 - Open
0.9558 - Bid 0.9522 x 100
- Ask 1.0300 x 100
- Day's Range
0.9500 - 1.0200 - 52 Week Range
0.6300 - 1.5800 - Volume
814,085 - Avg. Volume
280,804 - Market Cap (intraday)
55.406M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-1.1200 - Earnings Date Nov 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.54
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
www.luciddx.comRecent News: LUCD
View More
Performance Overview: LUCD
Trailing total returns as of 11/20/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LUCD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LUCD
View MoreValuation Measures
Market Cap
52.99M
Enterprise Value
107.49M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.61
Price/Book (mrq)
--
Enterprise Value/Revenue
25.66
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-101.02%
Return on Equity (ttm)
-1,007.83%
Revenue (ttm)
4.19M
Net Income Avi to Common (ttm)
-52.31M
Diluted EPS (ttm)
-1.1200
Balance Sheet and Cash Flow
Total Cash (mrq)
14.49M
Total Debt/Equity (mrq)
206.15%
Levered Free Cash Flow (ttm)
-39.47M
Research Analysis: LUCD
View MoreCompany Insights: LUCD
LUCD does not have Company Insights